Clinical Trial

Stockholm Mammography Risk Stratified Trial

Study acronym: SMART
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
SMART is a Phase III, randomised, non-blinded screening trial. Women who consent to participate in SMART are randomised to either individualised screening or screening according to the Swedish National Breast Cancer Screening Program. Women randomised to individualised screening get their 2-year risk of breast cancer assessed and women with the highest short-term risk are offered contrast enhanced mammography and a mammogram at 12 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-20.
Trial Details
NCT Number NCT06270355
Lead Sponsor Karolinska Institutet
Conditions Breast Cancer
Enrollment 70,000 participants
Start Date 2024-04-08
Primary Completion 2028-04-08 (estimated)
Study Completion 2032-04-08 (estimated)
Updated on ClinicalTrials.gov 2024-02-28